# A Study of LY2940680 in Japanese Participants With Advanced Cancers

> **NCT01919398** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 19 (actual)

## Conditions studied

- Neoplasm Metastasis

## Interventions

- **DRUG:** LY2940680

## Key facts

- **NCT ID:** NCT01919398
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-05
- **Final completion:** 2017-06-28
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01919398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01919398, "A Study of LY2940680 in Japanese Participants With Advanced Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01919398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*